Unichem gets US FDA approval for Atenolol and Chlorthalidone Tablets

They are indicated for the treatment of hypertension, to lower blood pressure

Unichem Laboratories has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations.

Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure.

The product will be commercialized from Unichem’s Ghaziabad Plant.

ANDA approvalAtenolol and Chlorthalidone TabletsHypertensionUnichem LaboratoriesUS FDA
Comments (0)
Add Comment